BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 16940367)

  • 1. Unusual case of well-differentiated papillary thyroid carcinoma lacking thyroglobulin expression while still concentrating radioiodine.
    Singh B; Bollmann R; Ahmadzadehfar H; Biersack HJ; Ezziddin S
    Br J Radiol; 2006 Sep; 79(945):e84-7. PubMed ID: 16940367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Non-iodine-absorbing metastasis of differentiated thyroid cancer--therapeutic probe with 13-cis retinoic acid].
    Kaniewski M; Czetwertyńska M; Godlewska P; Drac-Kaniewska J
    Wiad Lek; 2001; 54 Suppl 1():297-300. PubMed ID: 12182038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Promising radioiodine therapy of pulmonary metastases of a papillary carcinoma of the thyroid in a 12-year-old boy].
    Blattmann H; Beck A; Moser E
    Radiologe; 1992 Feb; 32(2):68-72. PubMed ID: 1565783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of rosiglitazone therapy in patients with thyroglobulin-positive and radioiodine-negative advanced differentiated thyroid cancer.
    Kebebew E; Lindsay S; Clark OH; Woeber KA; Hawkins R; Greenspan FS
    Thyroid; 2009 Sep; 19(9):953-6. PubMed ID: 19678746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should we routinely offer a second admission for radioiodine to patients with high-risk differentiated thyroid cancer?
    Gerrard GE; O'Toole L; Roberts F
    Clin Oncol (R Coll Radiol); 2010 Mar; 22(2):136-9. PubMed ID: 20152708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reinduction of cell differentiation and 131I uptake in a poorly differentiated thyroid tumor in response to the reverse transcriptase (RT) inhibitor nevirapine.
    Modoni S; Landriscina M; Fabiano A; Fersini A; Urbano N; Ambrosi A; Cignarelli M
    Cancer Biother Radiopharm; 2007 Apr; 22(2):289-95. PubMed ID: 17600478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lithium as adjuvant to radioiodine therapy in differentiated thyroid carcinoma: clinical and in vitro studies.
    Liu YY; van der Pluijm G; Karperien M; Stokkel MP; Pereira AM; Morreau J; Kievit J; Romijn JA; Smit JW
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):617-24. PubMed ID: 16712662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Embolization in combination with radioiodine therapy for bone metastases from differentiated thyroid carcinoma.
    Van Tol KM; Hew JM; Jager PL; Vermey A; Dullaart RP; Links TP
    Clin Endocrinol (Oxf); 2000 May; 52(5):653-9. PubMed ID: 10792347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of post-surgical stimulated thyroglobulin for radioiodine remnant ablation selection in low-risk papillary thyroid carcinoma.
    Vaisman A; Orlov S; Yip J; Hu C; Lim T; Dowar M; Freeman JL; Walfish PG
    Head Neck; 2010 Jun; 32(6):689-98. PubMed ID: 20187016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of total thyroidectomy with therapeutic central and lateral neck dissection with a single dose of radioiodine in the treatment of regionally advanced papillary thyroid cancer and effects on serum thyroglobulin.
    Hughes DT; Miller BS; Cohen MS; Doherty GM; Gauger PG
    Ann Surg Oncol; 2014 May; 21(5):1647-52. PubMed ID: 24385210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid remnant dose: 124I-PET/CT dosimetric comparison of rhTSH versus thyroid hormone withholding before radioiodine remnant ablation in differentiated thyroid cancer.
    Freudenberg LS; Frömke C; Petrich T; Marlowe RJ; Koska WW; Brandau W; Eising EG; Knust EJ; Bockisch A; Jentzen W
    Exp Clin Endocrinol Diabetes; 2010 Jul; 118(7):393-9. PubMed ID: 19856257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follow-up of differentiated thyroid carcinoma.
    Pagano L; Klain M; Pulcrano M; Angellotti G; Pasano F; Salvatore M; Lombardi G; Biondi B
    Minerva Endocrinol; 2004 Dec; 29(4):161-74. PubMed ID: 15765026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized clinical trial comparing 50mCi and 100mCi of iodine-131 for ablation of differentiated thyroid cancers.
    Zaman Mu; Toor R; Kamal S; Maqbool M; Habib S; Niaz K
    J Pak Med Assoc; 2006 Aug; 56(8):353-6. PubMed ID: 16967785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent differentiated thyroid cancer without elevation of serum thyroglobulin.
    Westbury C; Vini L; Fisher C; Harmer C
    Thyroid; 2000 Feb; 10(2):171-6. PubMed ID: 10718555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of thyroglobulin after thyroidectomy before ablative radioiodine therapy in thyroid cancer.
    Grünwald F; Menzel C; Fimmers R; Zamora PO; Biersack HJ
    J Nucl Med; 1996 Dec; 37(12):1962-4. PubMed ID: 8970514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of thyroglobulin to radioiodine therapy in thyroglobulin-elevated negative iodine scintigraphy (TENIS) syndrome.
    Sinha P; Conrad GR; West HC
    Anticancer Res; 2011 Jun; 31(6):2109-12. PubMed ID: 21737629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroglobulin flare response after radioiodine ablation in 2 patients with differentiated thyroid cancer.
    Tsang JF; Levin DP; Leslie WD
    Clin Nucl Med; 2015 May; 40(5):421-2. PubMed ID: 25546193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Usefulness of isotope diagnosis, ultrasound neck investigation and thyroglobulin assays in quantification of patients operated on for differentiated thyroid cancer and prepared for radioiodine treatment].
    Manuszewska-Jopek E; Bolko P; Łacka K; Ruchała M; Oleksa R; Majewski P; Sowiński J
    Pol Arch Med Wewn; 2003 Mar; 109(3):265-73. PubMed ID: 12924173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Results of radioiodine therapy in 47 patients with distant metastases of differentiated thyroid carcinoma].
    Miyamoto S; Kasagi K; Endo K; Iida Y; Hidaka A; Hatabu H; Konishi J
    Nihon Igaku Hoshasen Gakkai Zasshi; 1991 Jul; 51(7):810-21. PubMed ID: 1891347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary metastases in children and adolescents with well-differentiated thyroid cancer.
    Samuel AM; Rajashekharrao B; Shah DH
    J Nucl Med; 1998 Sep; 39(9):1531-6. PubMed ID: 9744337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.